2017 Indiana 100: After pulling CNO back, Bonach stepping aside
Q&A with Edward Bonach, CEO of CNO Financial Group: “Thankfully, I don’t know if it’s genes or what, but I can usually get by on less sleep than most. Starting early is good for me.”
Q&A with Edward Bonach, CEO of CNO Financial Group: “Thankfully, I don’t know if it’s genes or what, but I can usually get by on less sleep than most. Starting early is good for me.”
America's three insulin manufacturers—Indianapolis-based Eli Lilly and Co., Sanofi and Novo Nordisk—would face fines of $5,000 daily if they fail to provide the data.
Indiana hospitals are bracing for congressional action that could mean deep cuts in Medicaid, which funds the state’s popular health insurance program for low-income adults.
Continental Casualty Co., which has been tangling in court with the family for more than 15 years, recently initiated garnishment proceedings in a quest to collect as much as possible of a 2009 judgment.
Health insurer Centene Corp. plans a broad expansion of its Obamacare offerings next year at a time when many of its big rivals are retreating from the program.
In statehouses across the country and in Congress, drugmaker Alkermes is pushing its own addiction treatment while contributing to misconceptions and stigma about other medications used to treat opioid addiction.
The court's unanimous ruling Monday means a loss of billions in sales to makers of original versions of biologic drugs.
Besides contributing to overdoses, abuse of Opana ER was blamed for a 2015 outbreak of HIV and hepatitis C in southern Indiana linked to sharing needles, according to the FDA.
Just weeks after abandoning its proposed $48 billion merger with rival Cigna Corp., the Indianapolis-based health insurer is looking for its next deal. But this time, it is likely to be much smaller.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
One of the nation’s biggest health insurers says it will not return to Ohio’s public insurance exchanges next year, a decision that could open more holes in the Affordable Care Act’s increasingly thin system for helping people buy coverage.
Planned Parenthood of Indiana and Kentucky Inc. on Tuesday announced the hiring of a veteran not-for-profit leader to replace Betty Cockrum, who is retiring after 15 years as president and CEO of the organization.
A set of consolidated lawsuits accuse AbbVie and other makers of testosterone-replacement medicines, including Eli Lilly and Co., of hiding or downplaying their products’ risk for blood clots or other serious injuries.
Religious hospitals don't have to comply with federal laws protecting pension plans, a unanimous Supreme Court ruled Monday in a case that affects retirement benefits for roughly a million workers.
The first case against Bloomington-based Cook Group from patients who say the company’s blood-clot filters malfunctioned is headed for trial this fall in Indianapolis.
Prosecutors argue that subpoenas issued by counsel for the nursing home company's former CEO are overly broad and "an abuse of process."
Most of the cuts this summer will come from the hospital system’s billing operations in Indianapolis.
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.